Dr. Keith Bragman
Non-Executive Director
Keith has broad strategic and senior management experience at all stages of clinical drug development across diverse therapeutic areas.
He is currently an advisor to the industry and government-sponsored institutions on pharmaceutical development and associated business issues. He is an independent Director of BruCells SA, a biotechnology company that develops cellular vaccines for cancer treatment.
Previous appointments include senior clinical management positions in UCB S.A., Quintiles, Hoffmann-la Roche and Bristol Myers International Corporation. He is a member of the Ethical Issues Committee, Faculty of Pharmaceutical Medicine, Royal College of Physicians of London, and the Scientific Advisory Board, Unibioscreen SA.
